Yehuda Handelsman to Clinical Trials as Topic
This is a "connection" page, showing publications Yehuda Handelsman has written about Clinical Trials as Topic.
Connection Strength
0.512
-
POTENTIAL PLACE OF SGLT2 INHIBITORS IN TREATMENT PARADIGMS FOR TYPE 2 DIABETES MELLITUS. Endocr Pract. 2015 Sep; 21(9):1054-65.
Score: 0.119
-
Lessons from glargine trials: what is the goal fasting glucose with basal insulin? J Diabetes. 2014 Jul; 6(4):271-3.
Score: 0.110
-
Did AIM-HIGH aim too low? J Diabetes. 2012 Mar; 4(1):1-2.
Score: 0.095
-
An interview with the authors of Did AIM-HIGH aim too low. Interview by Jinghong Xu. J Diabetes. 2012 Mar; 4(1):3.
Score: 0.095
-
Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus? Expert Rev Clin Pharmacol. 2012 Jan; 5(1):43-54.
Score: 0.094